GHP Investment Advisors Inc. Acquires 6,476 Shares of CVS Health Corporation $CVS

GHP Investment Advisors Inc. lifted its holdings in CVS Health Corporation (NYSE:CVS) by 11.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,311 shares of the pharmacy operator’s stock after acquiring an additional 6,476 shares during the period. GHP Investment Advisors Inc.’s holdings in CVS Health were worth $4,367,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the business. Syverson Strege & Co bought a new position in shares of CVS Health in the 2nd quarter worth about $450,000. AlphaStar Capital Management LLC bought a new position in shares of CVS Health in the 2nd quarter worth about $385,000. AMG National Trust Bank raised its position in shares of CVS Health by 1.1% in the 2nd quarter. AMG National Trust Bank now owns 110,770 shares of the pharmacy operator’s stock worth $7,641,000 after acquiring an additional 1,258 shares in the last quarter. Simon Quick Advisors LLC raised its position in shares of CVS Health by 117.0% in the 2nd quarter. Simon Quick Advisors LLC now owns 17,388 shares of the pharmacy operator’s stock worth $1,199,000 after acquiring an additional 9,374 shares in the last quarter. Finally, Strs Ohio raised its position in shares of CVS Health by 1.7% in the 2nd quarter. Strs Ohio now owns 837,532 shares of the pharmacy operator’s stock worth $57,773,000 after acquiring an additional 14,278 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.22% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. Wells Fargo & Company lifted their price objective on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. The Goldman Sachs Group started coverage on CVS Health in a research report on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Royal Bank Of Canada boosted their target price on CVS Health from $81.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday. Piper Sandler boosted their target price on CVS Health from $81.00 to $99.00 in a research report on Friday. Finally, Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $87.91.

CVS Health Price Performance

CVS stock opened at $78.13 on Monday. The company has a market capitalization of $99.18 billion, a P/E ratio of 205.61, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The business has a 50-day simple moving average of $76.49 and a two-hundred day simple moving average of $69.04.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s payout ratio is 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.